Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The bidirectional association between diabetes and long-COVID-19 – A systematic review
Jessica L. Harding, Sofia Oviedo, Mohammed K. Ali, et al.
Diabetes Research and Clinical Practice (2022) Vol. 195, pp. 110202-110202
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
Matthew S. Durstenfeld, Michael J. Peluso, Punita Kaveti, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 542-554
Open Access | Times Cited: 23
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, et al.
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100733-100733
Open Access | Times Cited: 12
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
Nikolaos Perakakis, Hani Harb, Benjamin G. Hale, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 675-693
Open Access | Times Cited: 18
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
Single‐cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms
Hyundong Yoon, Logan S. Dean, Boonyanudh Jiyarom, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Long-COVID-19 autonomic dysfunction: An integrated view in the framework of inflammaging
Sergio Giunta, Chiara Giordani, María De Luca, et al.
Mechanisms of Ageing and Development (2024) Vol. 218, pp. 111915-111915
Closed Access | Times Cited: 5
The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 5
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022
Mark Steven Miller, Pauline Terebuh, David C. Kaelber, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2439444-e2439444
Open Access | Times Cited: 5
Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates
Aysha Alkhemeiri, Ziad El‐Khatib, Ali Al-Ameri, et al.
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes
Pandora L. Wander, Elliott Lowy, Anna Korpak, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317348-e0317348
Open Access
Long-term outcomes of post-acute sequelae of SARS-CoV-2 infection: a cohort study protocol
Dongquan Zhang, Zhen Tong, Xingwen Dong, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 12
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID‐19 patients: Comparison with influenza and pre‐pandemic data
Kevin Dell’Aquila, Jeylin Lee, Stephen Wang, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2482-2494
Closed Access | Times Cited: 12
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
Chiara Bellia, Aikaterini Andreadi, Ilenia D’Ippolito, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Diabetes, COVID‐19, and questions unsolved
F. D'Souza, Raffaella Buzzetti, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 5
Open Access | Times Cited: 8
Long COVID exhibits clinically distinct phenotypes at 3–6 months post-SARS-CoV-2 infection: results from the P4O2 consortium
Jelle M. Blankestijn, Mahmoud I. Abdel‐Aziz, Nadia Baalbaki, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e001907-e001907
Open Access | Times Cited: 2
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
(2023)
Open Access | Times Cited: 6
Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, et al.
Russian Journal of Cardiology (2023) Vol. 28, Iss. 4, pp. 5424-5424
Open Access | Times Cited: 5
Assessing the Risk of Stroke in the Elderly in the Context of Long-COVID, Followed Through the Lens of Family Medicine
Andrada Florina Moldovan, Ioana Moga, Titus David Moga, et al.
In Vivo (2023) Vol. 37, Iss. 5, pp. 2284-2295
Open Access | Times Cited: 5
Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis
Jithin Sam Varghese, Yi Guo, Mohammed K. Ali, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Post-COVID and diabetes mellitus
Lena Bandelin-Franke, Carmen Scheibenbogen, Thomas Bobbert
Deleted Journal (2024) Vol. 20, Iss. 3, pp. 356-363
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top